Success Stories: NAILG Helps Biomedical Scientist from Zimbabwe Achieve NIW Approval

 

Client’s Testimonial:

“I am extremely grateful to the Chen Immigration for their professionalism and expertise when I filed my EB-2 NIW petition. They were very helpful and answered all the questions I had during the process. In addition, they compiled an excellent petition packet which resulted in my case being approved with no RFE. I definitely recommend the team!”


On March 6th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist in the Field of Chemistry and Biochemistry (Approval Notice).


General Field: Chemistry and Biochemistry

Position at the Time of Case Filing: Scientist

Country of Origin: Zimbabwe

State of Residence at the Time of Filing: Massachusetts

Approval Notice Date: March 6th, 2025

Processing Time: 9 months, 27 days


Case Summary:

With a strong foundation in biomedical science and a commitment to advancing gene therapy, our client is making valuable contributions to the field. When she sought our assistance in filing an I-140 NIW (National Interest Waiver) petition, we conducted a thorough evaluation of her credentials and recognized the national significance of her work. Confident in the strength of her case, we guided her through the process and signed the retainer agreement.

To demonstrate her critical role in biomedical research, we highlighted key aspects of her contributions to the NIW petition:

  • She has authored six peer-reviewed journal articles, including two as the first author.
  • Her work has been cited 203 times, showcasing its recognition and impact within the scientific community.
  • Her research has been supported by funding from the National Institutes of Health (NIH), the National Institute on Aging (NIA), as well as the National Science Foundation (NSF).
Her proposed endeavor focuses on developing safe and effective gene therapies and delivery systems to improve treatment options for rare and complex disorders. Her research has been particularly influential in the study of Alzheimer’s disease, where she has helped uncover how protofibrils contribute to neuronal damage. By providing deeper insights into disease progression, her work supports the development of targeted drug therapies that could enhance patient outcomes.

To further strengthen her petition, we included recommendation letters from experts in her field. One of them emphasized:

"[Client]’s research has made significant strides in the treatment of Alzheimer’s disease. Her expertise is highly valued within the scientific community, and it is crucial that her work continues to advance chemistry and biochemistry in the United States."

With her extensive research experience and demonstrated contributions, she is well-positioned to drive further advancements in her field. We are pleased that our strategic approach in presenting her case led to a successful NIW approval. Her work stands as a testament to the importance of scientific innovation, and we are honored to have supported her in this process. We look forward to seeing the continued impact of her research in gene therapy and neurodegenerative disease treatment.